HIV NRTIs
competitively inhibit nucleotide binding to RT and terminate DNA chain
Abacavir, didanosine, emtricitabine, lamivudine, stavudine, tenofovir, zidovudine (can use for general prophylaxis and during pregnancy)
side fx: BM suppression, lactic acidosis, periph neuropathy
HIV NNRIs
Bind RT at diff site form NRTIs, don’t need phosphorylation to be active or compete w/ nucleotides
Delavirdine, efavirenz, nevirapine
Side fx: rash, hepatotoxicity. Efavirenz: C/I in preg; vivid dreams. Delavirdine C/I in preg
HIV Protease inhibitors
-navir suffix
“navir (never) tease a protease”
Prevent maturation of new viruses by inhibiting HIV-1 protease (pol gene)
Side fx: hyperglc, GI intolerance, lipodystrophy, nephropathy, hematuria, thrombocytopenia
Ritonavir boosts other drug concentrations by inhibiting P450. Rifamin decreases protease inhibitor concentrations; use rifabutin instead
HIV Integrase inhibitors
-tegravir suffix
Inhibit HIV genome integration into host cell chromosome by reversibly inhibiting HIV integrase
Can increase creatine kinase
HIV fusion inhibitors
Enfuvirtide: binds gp41, inhibiting viral entry. Can cause skin rxn at injection site
Maraviroc: binds CCR-5 on surface of T cells/monocytes, inhibiting interaction w/ gp120
Reye syndrome
Caused by treating viral infxn with aspirin. Aspirin metabolites reduce beta-oxidation by reversible inhibition of mitochondrial enzymes
Reye of sunSHINE: Steatosis of liver/hepatocytes Hypoglc/Hepatomegaly Infxn (VZV, flu) Not awake (coma) Encephalopathy: cerebral edema, d/t increased ammonia (hyperammonemia induces astrocyte edema, increasing ICP)